Sino Biopharmaceutical's market cap is currently $6.90B. The company's EPS TTM is $0.018; its P/E ratio is 19.58; and it has a dividend yield of 1.69%. Sino Biopharmaceutical is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is

lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 26.20B	¥ 28.78B	¥ 26.86B	¥ 23.65B	¥ 24.23B
Gross Profit	¥ 21.21B	¥ 22.98B	¥ 21.53B	¥ 18.46B	¥ 19.31B
Operating Income	¥ 5.79B	¥ 6.69B	¥ 18.86B	¥ 4.89B	¥ 5.81B
EBITDA	¥ 6.98B	¥ 6.69B	¥ 19.87B	¥ 6.54B	¥ 7.37B
Net Income	¥ 2.33B	¥ 5.00B	¥ 14.61B	¥ 4.34B	¥ 4.69B
Balance Sheet
Cash & Short-Term Investments	¥ 14.12B	¥ 16.92B	¥ 15.79B	¥ 16.43B	¥ 19.11B
Total Assets	¥ 63.60B	¥ 64.06B	¥ 60.54B	¥ 47.21B	¥ 58.30B
Total Debt	¥ 12.58B	¥ 13.98B	¥ 12.12B	¥ 14.21B	¥ 8.62B
Net Debt	¥ 3.13B	¥ 5.33B	¥ 2.52B	¥ 3.59B	¥ -2.02B
Total Liabilities	¥ 25.43B	¥ 26.12B	¥ 22.81B	¥ 24.79B	¥ 18.01B
Stockholders' Equity	¥ 30.47B	¥ 29.75B	¥ 30.29B	¥ 16.75B	¥ 31.11B
Cash Flow
Free Cash Flow	¥ 4.36B	¥ 4.56B	¥ 3.47B	¥ 3.47B	¥ 3.59B
Operating Cash Flow	¥ 6.07B	¥ 6.27B	¥ 5.37B	¥ 5.33B	¥ 5.32B
Investing Cash Flow	¥ -756.98M	¥ -4.07B	¥ -2.52B	¥ -7.85B	¥ -3.82B
Financing Cash Flow	¥ -6.55B	¥ -3.19B	¥ -3.23B	¥ 2.23B	¥ 2.80B

Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Income Statement >

Sino Biopharmaceutical Debt to Assets

Balance Sheet >

Sino Biopharmaceutical Cash Flow

Cash Flow >

Sino Biopharmaceutical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing